Disaccharide analysis of skin glycosaminoglycan in lichen myxedematosus
Corresponding Author
H Amano
* Corresponding author, Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan, tel. +81 27 220 8284; fax +81 27 220 8285; E-mail: [email protected]Search for more papers by this authorY Yokoyama
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorM Hasegawa
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorA Tamura
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorO Ishikawa
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorCorresponding Author
H Amano
* Corresponding author, Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan, tel. +81 27 220 8284; fax +81 27 220 8285; E-mail: [email protected]Search for more papers by this authorY Yokoyama
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorM Hasegawa
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorA Tamura
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorO Ishikawa
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
Search for more papers by this authorDOI: 10.1111/j.1468-3083.2008.02655.x
References
- 1 Yokoyama Y, Akimoto S, Ishikawa O. Disaccharide analysis of skin glycosaminoglycans in atrophoderma of Pasini and Pierini. Clin Exp Dermatol 2000; 25: 436–440.
- 2 Yokoyama Y, Ishikawa O, Miyachi Y. Disaccharide analysis of skin glycosaminoglycan in localized scleroderma. Dermatology 1997; 194: 329–333.
- 3 Ishikawa O, Kubota Y, Miyachi Y. Prostaglandin E1 suppresses tumor necrosis factor-alpha and interleukin-10 production by lipopolysaccharides-stimulated mononuclear cells. Eur J Pharmacol 1998; 344: 95–98.
- 4 Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273–281.
- 5 Turakainen H, Valimaki M, Penttinen R. Synthesis of glycosaminoglycans and collagen in skin fibroblasts cultured from a patient with lichen myxedematosus. Arch Dermatol Res 1985; 277: 55–59.
- 6 Yaron M, Yaron I, Yust I, Brenner S. Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts. J Rheumatol 1985; 12: 171–175.
- 7 Miller JW, Castor CW. Connective tissue activation XXVI: IgG stimulation of glycosaminoglycan synthesis in human synovial cultures. J Rheumatol 1983; 10: 190–196.
- 8 Triggs-Raine B, Salo TJ, Zang H, Wicklow BA, Natowicz MR. Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. Proc Natl Acad Sci USA 1999; 96: 6296–6300.
